GSA Capital Partners’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$540K	Sell	319,655 -157,826	-33%	-$280K	0.03%	866
2025 Q4	$678K	Buy	+477,481	New	+$696K	0.06%	616
2025 Q2	–	Sell	-10,153	Closed	-$8K	–	1779
2025 Q1	$8K	Sell	10,153 -112,869	-92%	-$130K	﹤0.01%	1594
2024 Q4	$170K	Buy	+123,022	New	+$138K	0.01%	1452
2024 Q1	–	Sell	-23,950	Closed	-$80K	–	1649
2023 Q4	$80K	Sell	23,950 -72,703	-75%	-$195K	0.01%	1406
2023 Q3	$361K	Sell	96,653 -24,726	-20%	-$114K	0.03%	977
2023 Q2	$518K	Buy	121,379 +55,702	+85%	+$329K	0.05%	709
2023 Q1	$449K	Sell	65,677 -11,362	-15%	-$88.2K	0.04%	783
2022 Q4	$610K	Buy	+77,039	New	+$593K	0.08%	477
2022 Q1	–	Sell	-17,781	Closed	-$284K	–	1459
2021 Q4	$284K	Buy	+17,781	New	+$311K	0.04%	970
2021 Q3	–	Sell	-12,453	Closed	-$172K	–	1470
2021 Q2	$172K	Buy	+12,453	New	+$176K	0.02%	1206
2020 Q1	–	Sell	-42,933	Closed	-$773K	–	1111
2019 Q4	$773K	Buy	42,933 +29,122	+211%	+$537K	0.09%	355
2019 Q3	$280K	Buy	+13,811	New	+$276K	0.04%	952